Curis (CRIS) Revenue (2010 - 2025)
Curis' (CRIS) quarterly Revenue came in at $1.1 million in Q4 2025, down 65.98% YoY from $3.3 million in Q4 2024, and down 64.17% on a QoQ basis from $3.2 million in Q3 2025.
Curis (CRIS) Revenue (2010 - 2025) Analysis & Trends
Curis (CRIS) has 16 years of Revenue data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Revenue fell 65.98% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.1 million (down 36.95% YoY) and the FY2025 annual result came in at $9.4 million, down 13.43% from the prior year.
- Revenue declined to $1.1 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $3.3 million in Q4 2024 to a low of $1.1 million in Q4 2025.
- A 5-year average of $2.6 million and a median of $2.6 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2024 — Revenue gained 24.07% — and 2025, when it sank 65.98%.
- Tracing CRIS's Revenue over 5 years: stood at $3.1 million in 2021, then slipped by 7.91% to $2.9 million in 2022, then fell by 6.62% to $2.7 million in 2023, then grew by 24.07% to $3.3 million in 2024, then slumped by 65.98% to $1.1 million in 2025.
- The last three Revenue figures came in at $1.1 million (Q4 2025), $3.2 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.89 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.04 Mn |
| Jun 30, 2021 | 2.29 Mn |
| Mar 31, 2021 | 2.19 Mn |